A clinical study to compare the effects of Satavari tablets and Amritadi tablets in Post Menopausal Syndrome.

Efficacy of Amritadi formulation in Post Menopausal Syndrome: A Randomized Controlled Trial - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/082229

Enrollment

Registered

2025-03-12

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N951- Menopausal and female climactericstates

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Female in the age group 45 to 55 years diagnosed with Post Menopausal Symptoms according to Menopause Rating Scale with a score above 14.

Exclusion criteria

Exclusion criteria: 1.Artificial Post Menopause -surgical,radiation,iatrogenic Post menopause. 2.Any known case of malignancy. 3.Known Psychiatric disorders. 4.Those who had undergone hormone therapy within the past 3 months 5.Participants who have completed 5 years after menopause.

Design outcomes

Primary

Measure	Time frame
Changes in score as per MRS Scale (ordinal data)Timepoint: Baseline, 61 -day, 91-day	—

Secondary

Measure	Time frame
Changes in Psychological General Wellbeing Index(PGWBI),Greene Climacteric Scale(GCS),Menopause-specific Quality of Life Questionnaire (MenQOL)Timepoint: Baseline, 61-day,91-day	—

Countries

India

Contacts

Public ContactDr Asha Sreedhar

Government Ayurveda College Thiruvananthapuram

drdeepamadhavank@gmail.com9446171568

Outcome results